Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)

Pieternella Johanna Lugtenburg; Peter de Nully Brown; Bronno van der Holt; Eva de Jongh; Josée M. Zijlstra

doi:10.1016/j.ejca.2024.115144

Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)

Pieternella Johanna Lugtenburg^*
, Peter de Nully Brown
, Bronno van der Holt
, Eva de Jongh
, Josée M. Zijlstra

^*Corresponding author for this work

Erasmus University Rotterdam
University of Copenhagen
Albert Schweitzer Ziekenhuis
Vrije Universiteit Amsterdam

Research output: Contribution to journal › Comment/Letter to the editor › Academic

29 Downloads (Pure)

Original language	English
Article number	115144
Journal	European Journal of Cancer
Volume	214
DOIs	https://doi.org/10.1016/j.ejca.2024.115144
Publication status	Published - 1 Jan 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2024.115144

Rituximab-maintenance-for-patients-with-diffuse-large-b-cell-lymphoma-in-first-complete-remission.pdfFinal published version, 540 KB

Cite this

Lugtenburg, P. J., Nully Brown, P. D., van der Holt, B., de Jongh, E., & Zijlstra, J. M. (2025). Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014). European Journal of Cancer, 214, Article 115144. https://doi.org/10.1016/j.ejca.2024.115144

Lugtenburg, Pieternella Johanna ; Nully Brown, Peter de ; van der Holt, Bronno et al. / Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission : Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014). In: European Journal of Cancer. 2025 ; Vol. 214.

@article{20fd7caaf3de4fb1aefebdcc98597088,

title = "Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)",

author = "Lugtenburg, \{Pieternella Johanna\} and \{Nully Brown\}, \{Peter de\} and \{van der Holt\}, Bronno and \{de Jongh\}, Eva and Zijlstra, \{Jos{\'e}e M.\}",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/j.ejca.2024.115144",

language = "English",

volume = "214",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

}

Lugtenburg, PJ, Nully Brown, PD, van der Holt, B, de Jongh, E & Zijlstra, JM 2025, 'Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)', European Journal of Cancer, vol. 214, 115144. https://doi.org/10.1016/j.ejca.2024.115144

Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014). / Lugtenburg, Pieternella Johanna; Nully Brown, Peter de; van der Holt, Bronno et al.
In: European Journal of Cancer, Vol. 214, 115144, 01.01.2025.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission

T2 - Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)

AU - Lugtenburg, Pieternella Johanna

AU - Nully Brown, Peter de

AU - van der Holt, Bronno

AU - de Jongh, Eva

AU - Zijlstra, Josée M.

PY - 2025/1/1

Y1 - 2025/1/1

UR - https://www.scopus.com/pages/publications/85210302230

U2 - 10.1016/j.ejca.2024.115144

DO - 10.1016/j.ejca.2024.115144

M3 - Comment/Letter to the editor

C2 - 39615333

SN - 0959-8049

VL - 214

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 115144

ER -

Lugtenburg PJ, Nully Brown PD, van der Holt B, de Jongh E, Zijlstra JM. Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014). European Journal of Cancer. 2025 Jan 1;214:115144. doi: 10.1016/j.ejca.2024.115144

Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)

UN SDGs

Access to Document

Other files and links

Cite this